Rafferty Asset Management, LLC Incyte Corp Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Incyte Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 282,621 shares of INCY stock, worth $21 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

282,621

Previous 303,084 6.75%

Holding current value

$21 Million

Previous $18.4 Million 1.68%

% of portfolio

0.06%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$57.33 - $68.61 $1.17 Million - $1.4 Million	-20,463 Reduced 6.75%	282,621 $18.7 Million
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $6.71 Million - $8.36 Million	131,099 Added 76.23%	303,084 $18.4 Million
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $626,517 - $737,750	-11,079 Reduced 6.05%	171,985 $9.8 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $1.28 Million - $1.57 Million	24,525 Added 15.47%	183,064 $11.5 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $262,102 - $299,124	4,537 Added 2.95%	158,539 $9.16 Million
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $2.61 Million - $3.24 Million	42,877 Added 38.58%	154,002 $9.59 Million
Q1 2023 May 11, 2023	SELL	$70.23 - $86.01 $197,627 - $242,032	-2,814 Reduced 2.47%	111,125 $8.03 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $547,248 - $685,160	8,146 Added 7.7%	113,939 $9.15 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $3.11 Million - $3.89 Million	46,944 Added 79.77%	105,793 $7.05 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $1.27 Million - $1.6 Million	-19,220 Reduced 24.62%	58,849 $4.47 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $585,861 - $707,346	-8,874 Reduced 10.21%	78,069 $6.2 Million
Q4 2021 Feb 10, 2022	SELL	$63.34 - $74.11 $1.16 Million - $1.36 Million	-18,288 Reduced 17.38%	86,943 $6.38 Million
Q3 2021 Nov 10, 2021	BUY	$68.67 - $84.02 $1.8 Million - $2.2 Million	26,189 Added 33.13%	105,231 $7.24 Million
Q2 2021 Aug 10, 2021	SELL	$79.87 - $87.53 $916,667 - $1 Million	-11,477 Reduced 12.68%	79,042 $6.65 Million
Q1 2021 May 10, 2021	BUY	$76.02 - $100.5 $2.59 Million - $3.42 Million	34,049 Added 60.3%	90,519 $7.36 Million
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $117,880 - $142,642	-1,460 Reduced 2.52%	56,470 $4.91 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $1.43 Million - $1.85 Million	16,824 Added 40.93%	57,930 $5.2 Million
Q2 2020 Aug 07, 2020	BUY	$74.18 - $108.93 $601,748 - $883,640	8,112 Added 24.59%	41,106 $4.27 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $2.61 Million - $3.55 Million	-41,275 Reduced 55.58%	32,994 $2.42 Million
Q4 2019 Feb 10, 2020	SELL	$73.04 - $95.72 $3.06 Million - $4.01 Million	-41,945 Reduced 36.09%	74,269 $6.49 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $1.52 Million - $1.81 Million	20,894 Added 21.92%	116,214 $8.63 Million
Q2 2019 Aug 09, 2019	BUY	$73.52 - $88.7 $792,030 - $955,565	10,773 Added 12.74%	95,320 $8.1 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $3.75 Million - $5.2 Million	58,957 Added 230.39%	84,547 $7.27 Million
Q4 2018 Feb 11, 2019	SELL	$58.5 - $69.94 $249,502 - $298,294	-4,265 Reduced 14.29%	25,590 $1.63 Million
Q3 2018 Nov 09, 2018	SELL	$61.75 - $74.23 $305,971 - $367,809	-4,955 Reduced 14.23%	29,855 $2.06 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $1.02 Million - $1.41 Million	16,792 Added 93.2%	34,810 $2.33 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $227,833 - $276,988	2,743 Added 17.96%	18,018 $1.5 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $201,434 - $251,039	2,153 Added 16.41%	15,275 $1.45 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $1.43 Million - $1.81 Million	13,122	13,122 $1.53 Million

Others Institutions Holding INCY

# of Institutions

657

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Incyte Corp Transaction History